Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
| 17 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 124793 |
| 201 | 2 | IMMUNOTHERAPY//DENDRITIC CELLS//MYELOID DERIVED SUPPRESSOR CELLS | 20719 |
| 34757 | 1 | ARTIFICIAL ANTIGEN PRESENTING CELLS//HLA IG DIMER//LARGE MULTIVALENT IMMUNOGEN VACCINE | 121 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ARTIFICIAL ANTIGEN PRESENTING CELLS | authKW | 1754736 | 13% | 42% | 16 |
| 2 | HLA IG DIMER | authKW | 520943 | 2% | 100% | 2 |
| 3 | LARGE MULTIVALENT IMMUNOGEN VACCINE | authKW | 520943 | 2% | 100% | 2 |
| 4 | PARACRINE DELIVERY | authKW | 468846 | 2% | 60% | 3 |
| 5 | DIFFUSIVE INTERACTIONS | authKW | 347294 | 2% | 67% | 2 |
| 6 | ACTIVE AND ADOPTIVE IMMUNOTHERAPY | authKW | 260471 | 1% | 100% | 1 |
| 7 | ANTI HLA CLASS I PEPTIDE ANTIBODY | authKW | 260471 | 1% | 100% | 1 |
| 8 | ANTIBODY PEPTIDE MHC CONJUGATES | authKW | 260471 | 1% | 100% | 1 |
| 9 | ANTIBODY VACCINE GRP MP88CANC SCI UNIT | address | 260471 | 1% | 100% | 1 |
| 10 | ANTIGEN SPECIFIC T CELLS ACTIVATION | authKW | 260471 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Immunology | 756 | 38% | 0% | 46 |
| 2 | Oncology | 286 | 26% | 0% | 32 |
| 3 | Medicine, Research & Experimental | 112 | 12% | 0% | 15 |
| 4 | Materials Science, Biomaterials | 65 | 4% | 0% | 5 |
| 5 | Biochemical Research Methods | 60 | 8% | 0% | 10 |
| 6 | Cell Biology | 36 | 11% | 0% | 13 |
| 7 | Nanoscience & Nanotechnology | 33 | 7% | 0% | 8 |
| 8 | Biotechnology & Applied Microbiology | 32 | 8% | 0% | 10 |
| 9 | Hematology | 15 | 4% | 0% | 5 |
| 10 | Engineering, Biomedical | 14 | 3% | 0% | 4 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ANTIBODY VACCINE GRP MP88CANC SCI UNIT | 260471 | 1% | 100% | 1 |
| 2 | DEV GENES HUMAN DIS EDUC MINIST | 260471 | 1% | 100% | 1 |
| 3 | HLTH SCI EXPT IMMUNOL | 260471 | 1% | 100% | 1 |
| 4 | INTERISCIPLINARY ONCOL | 260471 | 1% | 100% | 1 |
| 5 | LMMUNOBIOL INTERNAL MED | 260471 | 1% | 100% | 1 |
| 6 | MALONE ENGN 415 | 260471 | 1% | 100% | 1 |
| 7 | MED IGEN | 260471 | 1% | 100% | 1 |
| 8 | PLURIPOTENT STEM CELL TRANSLAT | 260471 | 1% | 100% | 1 |
| 9 | SOUTHAMPTON CANC UK CANC SCI UNIT | 260471 | 1% | 100% | 1 |
| 10 | MALONE ENGN | 250445 | 4% | 19% | 5 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 2870 | 6% | 0% | 7 |
| 2 | JOURNAL OF IMMUNOLOGICAL METHODS | 1710 | 7% | 0% | 8 |
| 3 | ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING | 1548 | 1% | 1% | 1 |
| 4 | IMMUNITY & AGEING | 1504 | 1% | 1% | 1 |
| 5 | CLINICAL IMMUNOLOGY | 1499 | 3% | 0% | 4 |
| 6 | NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE | 703 | 2% | 0% | 2 |
| 7 | JOURNAL OF IMMUNOTHERAPY | 607 | 2% | 0% | 2 |
| 8 | CANCER IMMUNOLOGY RESEARCH | 510 | 1% | 0% | 1 |
| 9 | CLINICAL CANCER RESEARCH | 419 | 4% | 0% | 5 |
| 10 | TRENDS IN BIOTECHNOLOGY | 415 | 2% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |